journal article·2023-08-30Open access

Green SPIONs as a novel highly selective treatment for leishmaniasis: an in vitro study against Leishmania amazonensis intracellular amastigotes

Brunno Renato Farias Verçoza, Robson Roney Bernardo, Luiz Augusto Sousa de Oliveira, Juliany Cola Fernandes Rodrigues

Abstract

The main goal of this work was to evaluate the therapeutic potential of green superparamagnetic iron oxide nanoparticles (SPIONs) produced with coconut water for treating cutaneous leishmaniasis caused by Leishmania amazonensis . Optical and electron microscopy techniques were used to evaluate the effects on cell proliferation, infectivity percentage, and ultrastructure. SPIONs were internalized by both parasite stages, randomly distributed in the cytosol and located mainly in membrane-bound compartments. The selectivity index for intracellular amastigotes was more than 240 times higher compared to current drugs used to treat the disease. The synthesized SPIONs showed promising activity against Leishmania and can be considered a strong candidate for a new therapeutic approach for treating leishmaniases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Research on Leishmaniasis Studies · Papaya Research and Applications · Insect Pest Control Strategies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (35)

Show source-provided references
1. 10.4103/0974-777x.6288710.4103/0974-777x.62887 ↗
2. 10.1128/cmr.19.1.111-126.200610.1128/cmr.19.1.111-126.2006 ↗
3. 10.1007/978-3-319-74186-410.1007/978-3-319-74186-4 ↗
4. 10.1093/jac/33.2.20310.1093/jac/33.2.203 ↗
5. 10.1007/s11095-016-1958-510.1007/s11095-016-1958-5 ↗
6. 10.1039/b911626e10.1039/b911626e ↗
7. 10.1038/nnano.2011.9510.1038/nnano.2011.95 ↗
8. 10.2217/nnm-2018-050010.2217/nnm-2018-0500 ↗
9. 10.1016/j.ultsonch.2018.01.02210.1016/j.ultsonch.2018.01.022 ↗
10. 10.1038/s41598-018-37670-910.1038/s41598-018-37670-9 ↗
11. 10.1016/j.msec.2017.02.14510.1016/j.msec.2017.02.145 ↗
12. 10.2147/ijn.s16100210.2147/ijn.s161002 ↗
13. 10.1016/j.bbrc.2015.10.13610.1016/j.bbrc.2015.10.136 ↗
14. 10.3390/scipharm8504003610.3390/scipharm85040036 ↗
15. 10.2147/ijn.s11241510.2147/ijn.s112415 ↗
16. 10.1007/s10529-017-2477-010.1007/s10529-017-2477-0 ↗
17. 10.1371/journal.pone.017704910.1371/journal.pone.0177049 ↗
18. 10.1016/j.mib.2013.07.01810.1016/j.mib.2013.07.018 ↗
19. 10.1111/j.1462-5822.2007.01095.x10.1111/j.1462-5822.2007.01095.x ↗
20. 10.1016/j.pt.2013.07.00710.1016/j.pt.2013.07.007 ↗
21. 10.1007/s10495-017-1397-810.1007/s10495-017-1397-8 ↗
22. 10.1016/j.exppara.2013.06.01510.1016/j.exppara.2013.06.015 ↗
23. 10.1093/jac/dky22910.1093/jac/dky229 ↗
24. 10.1128/aac.01980-1910.1128/aac.01980-19 ↗
25. 10.1016/j.ejps.2015.01.01510.1016/j.ejps.2015.01.015 ↗
26. 10.1016/j.bmc.2017.03.05110.1016/j.bmc.2017.03.051 ↗
27. 10.1016/s0753-3322(01)00068-310.1016/s0753-3322(01)00068-3 ↗
28. 10.1093/jn/134.11.3171s10.1093/jn/134.11.3171s ↗
29. 10.1017/s003118200999188010.1017/s0031182009991880 ↗
30. 10.1371/journal.pntd.000206110.1371/journal.pntd.0002061 ↗
31. 10.1002/1521-4141(200012)30:12<3732::aid-immu3732>3.0.co;2-d10.1002/1521-4141(200012)30:12<3732::aid-immu3732>3.0.co;2-d ↗
32. 10.1016/j.parepi.2020.e0015610.1016/j.parepi.2020.e00156 ↗
33. 10.1016/j.actatropica.2017.04.02910.1016/j.actatropica.2017.04.029 ↗
34. 10.1007/978-3-319-70299-5_1310.1007/978-3-319-70299-5_13 ↗
35. 10.1021/jm000257810.1021/jm0002578 ↗